(Q43216738)

16 November 2017

title

A comparison of DNA vaccines for the rabies-related virus, Mokola (English)

1 reference

16 November 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00036-7

2 January 2024

author

Charles Edward Rupprecht

6

object named as

Rupprecht CE

1 reference

16 November 2017

1

L. H. Nel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744896

2 January 2024

author name string

M. Niezgoda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744896

2 January 2024

C. A. Hanlon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744896

2 January 2024

P. A. Morril

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744896

2 January 2024

P. A. Yager

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744896

2 January 2024

language of work or name

English

0 references

publication date

1 June 2003

1 reference

16 November 2017

2 June 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12744896

full work available at URL

2 January 2024

https://api.elsevier.com/content/article/PII:S0264410X03000367?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00036-7

https://api.elsevier.com/content/article/PII:S0264410X03000367?httpAccept=text/plain

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00036-7

2 January 2024

1 reference

16 November 2017

volume

21

1 reference

16 November 2017

issue

19-20

1 reference

16 November 2017

page(s)

2598-2606

1 reference

New cases of Mokola virus infection in South Africa: a genotypic comparison of Southern African virus isolates.

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Molecular diversity of the Lyssavirus genus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Characterisation of a novel lyssavirus isolated from Pteropid bats in Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Mokola virus infection in cats and a dog in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Isolation and characterization of 115 street rabies virus isolates from Ethiopia by using monoclonal antibodies: identification of 2 isolates as Mokola and Lagos bat viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Immunization of dogs and cats with a DNA vaccine against rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Chimeric lyssavirus glycoproteins with increased immunological potential

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Immune responses to nucleic acid vaccines to rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Immune responses to DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Liposome-mediated DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Report of isolations of unusual lyssaviruses (rabies and Mokola virus) identified retrospectively from Zimbabwe.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Evidence for a viral superantigen in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900036-7

7 January 2021

Mokola Virus

5

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00036-7

A Fatal Human Infection with Mokola Virus *

2 January 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00036-7

Mokola virus infection: description of recent South African cases and a review of the virus epidemiology.

2 January 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00036-7

2 January 2024

Identifiers

1 reference

16 November 2017

1 reference